Cargando…
Expression of MAS1 in breast cancer
MAS1 is a receptor for angiotensin 1-7 (A1-7), which is derived from angiotensin II (A-II) by the action of angiotensin converting enzyme (ACE) 2. MAS1 induces anti-A-II phenotypes, such as vessel dilation and depression of blood pressure. Using immunohistochemistry, we examined the role of MAS1 in...
Autores principales: | Luo, Yi, Tanabe, Eriko, Kitayoshi, Misaho, Nishiguchi, Yukiko, Fujiwara, Rina, Matsushima, Sayako, Sasaki, Takamitsu, Sasahira, Tomonori, Chihara, Yoshitomo, Nakae, Dai, Fujii, Kiyomu, Ohmori, Hitoshi, Kuniyasu, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Ltd
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582995/ https://www.ncbi.nlm.nih.gov/pubmed/26080617 http://dx.doi.org/10.1111/cas.12719 |
Ejemplares similares
-
Fatty acids inhibit anticancer effects of 5-fluorouracil in mouse cancer cell lines
por: Tanabe, Eriko, et al.
Publicado: (2017) -
Significance of intranuclear angiotensin-II type 2 receptor in oral squamous cell carcinoma
por: Matsushima-Otsuka, Sayako, et al.
Publicado: (2018) -
Expression of cytosolic malic enzyme (ME1) is associated with disease progression in human oral squamous cell carcinoma
por: Nakashima, Chie, et al.
Publicado: (2018) -
Gemcitabine Resistance in Pancreatic Ductal Carcinoma Cell Lines Stems from Reprogramming of Energy Metabolism
por: Fujiwara-Tani, Rina, et al.
Publicado: (2022) -
Effect of Proton Pump Inhibitors on Colorectal Cancer
por: Sasaki, Takamitsu, et al.
Publicado: (2020)